QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
LON:GNS

Genus (GNS) Share Forecast, Price & News

GBX 2,458
-16.00 (-0.65%)
(As of 06/7/2023 ET)
Compare
Today's Range
2,450
2,476
50-Day Range
2,448
2,893.92
52-Week Range
2,196
3,364
Volume
38,236 shs
Average Volume
94,524 shs
Market Capitalization
£1.62 billion
P/E Ratio
4,726.92
Dividend Yield
1.30%
Price Target
GBX 4,500

Genus MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
83.1% Upside
GBX 4,500 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
£2.48 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.83 out of 5 stars


GNS stock logo

About Genus (LON:GNS) Stock

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Receive GNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter.

GNS Stock News Headlines

Peel Hunt Reaffirms Buy Rating for Genus (LON:GNS)
"Chilling War Games Show US Forces Crushed" – FOX NEWS
=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
Genus (LON:GNS) Sets New 1-Year Low at $2,196.00
Genus plc (GNS.L)
"Chilling War Games Show US Forces Crushed" – FOX NEWS
=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
Genus' (LON:GNS) Dividend Will Be £0.217
Genus (LON:GNS) Will Pay A Dividend Of £0.217
How the Chile Became Hot - The New York Times
See More Headlines

GNS Price History

GNS Company Calendar

Ex-Dividend for 3/30 Dividend
3/02/2023
Dividend Payable
3/30/2023
Today
6/07/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
3,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 4,500
High Stock Price Forecast
GBX 4,500
Low Stock Price Forecast
GBX 4,500
Forecasted Upside/Downside
+82.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
£34.40 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£662.40 million
Cash Flow
GBX 48.73 per share
Book Value
GBX 882 per share

Miscellaneous

Free Float
N/A
Market Cap
£1.62 billion
Optionable
Not Optionable
Beta
0.41

Key Executives

  • Mr. Stephen Wilson (Age 63)
    CEO & Exec. Director
    Comp: $880k
  • Ms. Alison Henriksen (Age 56)
    CFO & Exec. Director
    Comp: $647k
  • Dr. William Christianson
    Chief Operating Officer
  • Dr. Elena Rice
    Head of R&D and Chief Scientific Officer
  • Mr. Dan Hartley
    Group Gen. Counsel & Company Sec.
  • Ms. Angelle R. Rosata
    Group HR Director
  • Mr. Jerry Thompson
    Chief Operating Officer of Genus ABS Beef
  • Dr. Nate Zwald
    Chief Operating Officer of Genus ABS Dairy
  • Ms. Janet Duane
    Group Financial Controller













GNS Stock - Frequently Asked Questions

Should I buy or sell Genus stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genus in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" GNS shares.
View GNS analyst ratings
or view top-rated stocks.

What is Genus' stock price forecast for 2023?

1 analysts have issued 1 year target prices for Genus' stock. Their GNS share price forecasts range from GBX 4,500 to GBX 4,500. On average, they anticipate the company's stock price to reach GBX 4,500 in the next twelve months. This suggests a possible upside of 82.6% from the stock's current price.
View analysts price targets for GNS
or view top-rated stocks among Wall Street analysts.

How have GNS shares performed in 2023?

Genus' stock was trading at GBX 2,984 at the start of the year. Since then, GNS shares have decreased by 17.4% and is now trading at GBX 2,463.97.
View the best growth stocks for 2023 here
.

How often does Genus pay dividends? What is the dividend yield for Genus?

Genus declared a dividend on Thursday, February 23rd. Investors of record on Thursday, March 2nd will be paid a dividend of GBX 10.30 per share on Thursday, March 30th. This represents a dividend yield of 0.38%. The ex-dividend date of this dividend is Thursday, March 2nd. The official announcement can be viewed at this link.
Read our dividend analysis for GNS
.

Is Genus a good dividend stock?

Genus (LON:GNS) pays an annual dividend of GBX 32 per share and currently has a dividend yield of 1.27%. The dividend payout ratio is 6,153.85%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for GNS.

What other stocks do shareholders of Genus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genus investors own include Clinigen Group (CLIN), Glencore (GLEN), Tesco (TSCO), AstraZeneca (AZN), British American Tobacco (BATS), Cronos Group (CRON), Dairy Crest Group (DCG), Debenhams (DEB), Diageo (DGE) and Experian (EXPN).

What is Genus' stock symbol?

Genus trades on the London Stock Exchange (LON) under the ticker symbol "GNS."

How do I buy shares of Genus?

Shares of GNS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Genus' stock price today?

One share of GNS stock can currently be purchased for approximately GBX 2,463.97.

How much money does Genus make?

Genus (LON:GNS) has a market capitalization of £1.62 billion and generates £662.40 million in revenue each year. The company earns £34.40 million in net income (profit) each year or GBX 0.52 on an earnings per share basis.

How many employees does Genus have?

The company employs 3,400 workers across the globe.

How can I contact Genus?

Genus' mailing address is Matrix House, Basing View, BASINGSTOKE, RG21 4DZ, United Kingdom. The official website for the company is www.genusplc.com. The company can be reached via phone at +44-1256-347100.

This page (LON:GNS) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -